1
|
Iya AM, Beyer K, Kotecha P, Kibaru J, Abdullahi M, Alhassan SU, Mustapha MI, Ahmad A, Lawal Y, Rabiu Ibrahim J, Aminu A, Abubakar A, Saleh A, Bryan RT, Van Hemelrijck M, Russell B. Scoping review: bladder cancer in Nigeria - what are the gaps in clinical care and research? BMJ Open 2022; 12:e049241. [PMID: 35260447 PMCID: PMC8905928 DOI: 10.1136/bmjopen-2021-049241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
OBJECTIVES There are currently no national guidelines regarding bladder cancer treatment and clinical care pathways in Nigeria. The aim of this scoping review was to identify any gaps in the knowledge of epidemiology, clinical care and translational research in order to aid the development of a defined clinical care pathway and guide future research. METHODS A scoping review was conducted by searching Medline, Ovid Gateway, The Cochrane library and Open Grey literature using predefined search terms from date of inception to June 2020. Studies were included if they discussed the epidemiology or treatment pathway of bladder cancer. All data were charted and were analysed in a descriptive manner. A consultation phase was also conducted consisting of a multidisciplinary team of clinicians and bladder cancer survivors. RESULTS A total of 19 studies were deemed suitable for inclusion. The themes included the epidemiology of bladder cancer (high prevalence of schistosomiasis), research surrounding the biology of the disease and translational research including potential biomarkers. The consultation phase highlighted some possible sociocultural and infrastructural issues relating to both the diagnosis and treatment of bladder cancer, with poor knowledge of bladder cancer and its symptoms within the general population identified as a key issue. CONCLUSION Even though the factors surrounding the relationship between schistosomiasis and the histopathology of bladder cancer remain unclear, there is potential for screening for schistosomiasis in endemic regions of sub-Saharan Africa. Other key areas for future research include the dissemination of information to the general population surrounding bladder cancer and its symptoms to encourage prompt diagnosis.
Collapse
Affiliation(s)
| | - Katharina Beyer
- Translational Oncology and Urology Research, King's College London, London, UK
| | - Pinky Kotecha
- Translational Oncology and Urology Research, King's College London, London, UK
| | - Joyce Kibaru
- Translational Oncology and Urology Research, King's College London, London, UK
| | - Muzzammil Abdullahi
- Urology Unit, Aminu Kano Teaching Hospital, Kano, Nigeria
- Urology, Bayero University College of Health Sciences, Kano, Nigeria
| | | | | | | | - Yusuf Lawal
- Radiology Department, Aminu Kano Teaching Hospital, Kano, Nigeria
| | | | - Aliyu Aminu
- Microbiology, Aminu Kano Teaching Hospital, Kano, Nigeria
| | | | - Abdullahi Saleh
- Nursing department, Aminu Kano Teaching Hospital, Kano, Nigeria
| | - Richard T Bryan
- Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK
| | | | - Beth Russell
- Translational Oncology and Urology Research, King's College London, London, UK
| |
Collapse
|
2
|
Gong Z, Huang L, Tang X, Chen K, Wu Z, Zhang L, Sun Y, Xia Y, Chen H, Wei Y, Wang F, Guo S. Acoustic Droplet Printing Tumor Organoids for Modeling Bladder Tumor Immune Microenvironment within a Week. Adv Healthc Mater 2021; 10:e2101312. [PMID: 34558233 DOI: 10.1002/adhm.202101312] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2021] [Revised: 08/28/2021] [Indexed: 12/30/2022]
Abstract
Current organoid models are limited by the incapability of rapidly fabricating organoids that can mimic the immune microenvironment for a short term. Here, an acoustic droplet-based platform is presented to facilitate the rapid formation of tumor organoids, which retains the original tumor immune microenvironment and establishes a personalized bladder cancer tumor immunotherapy model. In combination with a hydrophobic substrate, the acoustic droplet printer can yield a large number of homogeneous and highly viable bladder tumor organoids in vitro within a week. The generated organoids consist of all components of bladder tumor, including diverse immune elements and tumor cells. By coculturing tumor organoids with autologous immune cells for 2 days, tumor reactive T cells are induced in vitro. Furthermore, it is also demonstrated that these tumor-reactive T cells can also enhance the killing efficiency of matched organoids. Because of the easy operation, repeatability, and stability, the proposed acoustic droplet platform will provide a reliable approach for personalized tumor immunotherapy.
Collapse
Affiliation(s)
- Zhiyi Gong
- Key Laboratory of Artificial Micro‐ and Nano‐Structures of Ministry of Education School of Physics and Technology Wuhan University Wuhan 430072 China
| | - Lanxiang Huang
- Department of Laboratory Medicine and Center for Single‐Cell Omics and Tumor Liquid Biopsy Zhongnan Hospital of Wuhan University Wuhan 430071 China
- Wuhan Research Center for Infectious Diseases and Cancer Chinese Academy of Medical Sciences Wuhan 430071 China
| | - Xuan Tang
- Department of Laboratory Medicine and Center for Single‐Cell Omics and Tumor Liquid Biopsy Zhongnan Hospital of Wuhan University Wuhan 430071 China
- Wuhan Research Center for Infectious Diseases and Cancer Chinese Academy of Medical Sciences Wuhan 430071 China
| | - Keke Chen
- Key Laboratory of Artificial Micro‐ and Nano‐Structures of Ministry of Education School of Physics and Technology Wuhan University Wuhan 430072 China
| | - Zhuhao Wu
- Key Laboratory of Artificial Micro‐ and Nano‐Structures of Ministry of Education School of Physics and Technology Wuhan University Wuhan 430072 China
| | - Lingling Zhang
- Department of Laboratory Medicine and Center for Single‐Cell Omics and Tumor Liquid Biopsy Zhongnan Hospital of Wuhan University Wuhan 430071 China
| | - Yue Sun
- Key Laboratory of Artificial Micro‐ and Nano‐Structures of Ministry of Education School of Physics and Technology Wuhan University Wuhan 430072 China
| | - Yu Xia
- Key Laboratory of Artificial Micro‐ and Nano‐Structures of Ministry of Education School of Physics and Technology Wuhan University Wuhan 430072 China
| | - Hui Chen
- Key Laboratory of Artificial Micro‐ and Nano‐Structures of Ministry of Education School of Physics and Technology Wuhan University Wuhan 430072 China
| | - Yongchang Wei
- Department of Radiation and Medical Oncology Zhongnan Hospital of Wuhan University Wuhan 430071 China
| | - Fubing Wang
- Department of Laboratory Medicine and Center for Single‐Cell Omics and Tumor Liquid Biopsy Zhongnan Hospital of Wuhan University Wuhan 430071 China
- Wuhan Research Center for Infectious Diseases and Cancer Chinese Academy of Medical Sciences Wuhan 430071 China
| | - Shishang Guo
- Key Laboratory of Artificial Micro‐ and Nano‐Structures of Ministry of Education School of Physics and Technology Wuhan University Wuhan 430072 China
| |
Collapse
|
3
|
Van Hemelrijck M, Peters V, Loong JF, Russell B, Fox L, Wylie H, Santaolalla A, Beyer K, Rammant E, Lin E, Haire A, Moss C, Green S. The importance of patient and public involvement in cancer research: time to create a new job profile. Future Oncol 2021; 17:3667-3670. [PMID: 34213357 DOI: 10.2217/fon-2021-0489] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Tweetable abstract Need to add #PPI coordinator to required job profiles in #research: improve research quality, enthuse research team and ensure #patients and their families are the center of our research activities.
Collapse
Affiliation(s)
- Mieke Van Hemelrijck
- Translational Oncology & Urology Research, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK
| | | | | | - Beth Russell
- Translational Oncology & Urology Research, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK
| | - Louis Fox
- Translational Oncology & Urology Research, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK
| | - Harriet Wylie
- Translational Oncology & Urology Research, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK
| | - Aida Santaolalla
- Translational Oncology & Urology Research, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK
| | - Katharina Beyer
- Translational Oncology & Urology Research, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK
| | - Elke Rammant
- Translational Oncology & Urology Research, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK
| | - E Lin
- Translational Oncology & Urology Research, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK
| | - Anna Haire
- Translational Oncology & Urology Research, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK
| | - Charlotte Moss
- Translational Oncology & Urology Research, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK
| | - Saran Green
- Translational Oncology & Urology Research, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK
| |
Collapse
|